Chemoinformaics analysis of Tetratriacontanoic acid
| Molecular Weight | 508.916 | nRot | 32 |
| Heavy Atom Molecular Weight | 440.372 | nRig | 31 |
| Exact Molecular Weight | 508.522 | nRing | 0 |
| Solubility: LogS | -2.665 | nHRing | 0 |
| Solubility: LogP | 4.012 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 104 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 68 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 103.726 |
| nHD | 1 | BPOL | 69.0861 |
| QED | 0.478 |
| Synth | 4.151 |
| Natural Product Likeliness | 1.32 |
| NR-PPAR-gamma | 0.049 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.784 |
| Pgp-sub | 0.947 |
| HIA | 0.004 |
| CACO-2 | -5.591 |
| MDCK | 0.00000995 |
| BBB | 0.881 |
| PPB | 0.937169 |
| VDSS | 2.222 |
| FU | 0.047187 |
| CYP1A2-inh | 0.063 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.236 |
| CYP2d6-inh | 0.667 |
| CYP2d6-sub | 0.939 |
| CYP3a4-inh | 0.116 |
| CYP3a4-sub | 0.926 |
| CL | 4.735 |
| T12 | 0.249 |
| hERG | 0.974 |
| Ames | 0.033 |
| ROA | 0.848 |
| SkinSen | 0.65 |
| Carcinogencity | 0.031 |
| EI | 0.007 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.519 |
| Antiviral | No |
| Prediction | 0.622537 |